Genomic and cellular pathology of lung cancer

Sandy D. Der, Roya Navab, Kota Ishizawa, Ming Sound Tsao

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.

Original languageEnglish
Pages (from-to)313-322
Number of pages10
JournalCurrent Respiratory Medicine Reviews
Issue number5
Publication statusPublished - 2011 Oct 1
Externally publishedYes


  • Biomarkers
  • Cancer stem cell
  • Cancer-associated fibroblasts
  • Genomics
  • Lung cancer
  • Oncogene
  • Personalized medicine
  • Stroma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Genomic and cellular pathology of lung cancer'. Together they form a unique fingerprint.

Cite this